Skip to content

AnaptysBio, Inc. ANAB Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$266.8M+13.8%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
$1.36M-2.3%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$143.22M+119%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$18.66M+84.3%
Precigen logo
PrecigenPGEN
$4.73M-12.7%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$40.77M+0.5%

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%
Total assets$329.7M-21.9%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.73B+180%
Enterprise value$1.48B+176%
P/S7.4×+1.9×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s operating lease liabilities (total)?
AnaptysBio, Inc. (ANAB) reported operating lease liabilities (total) of $13.61K in Q1 2026.
How has AnaptysBio, Inc.'s operating lease liabilities (total) changed year-over-year?
AnaptysBio, Inc.'s operating lease liabilities (total) decreased by 99.9% year-over-year, from $15.58M to $13.61K.
What is the long-term trend for AnaptysBio, Inc.'s operating lease liabilities (total)?
Over 5 years (2020 to 2025), AnaptysBio, Inc.'s operating lease liabilities (total) has grown at a -47.1% compound annual growth rate (CAGR), from $342K to $14.11K.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.